Elixir’s focal stress system to treat calcified lesions hits success in trial
Elixir reported high rates of clinical success with its LithiX Hertz Contact IVL system at EuroPCR 2024.
Elixir reported high rates of clinical success with its LithiX Hertz Contact IVL system at EuroPCR 2024.
The company received the award to conduct a trial assessing correlates of protection following Covid-19 vaccination.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
MMI pioneers Symani Surgical System in first US cases
“Defensibility” key for AI-centric small biotechs seeking investment
Klineo wins €2m to advance AI patient recruitment platform